An update from Apiam Animal Health Ltd. ( (AU:AHX) ) is now available.
Apiam Animal Health Ltd. reported resilient financial results for H1 FY25 despite facing industry challenges, such as reduced equine clinic and diagnostic revenues due to a pause in dairy heifer exports to China. The company’s diversified business model, particularly the strong performance of its Intensive Animal Veterinary Services segment, supported its revenue growth. A strategic review led to the decision to divest three underperforming businesses, which is expected to reduce revenue by $2.3 million but increase EBIT by $1 million. Additionally, an impairment loss of $4.5 million was recorded due to the divestment of an underperforming equine business in New South Wales.
More about Apiam Animal Health Ltd.
Apiam Animal Health Ltd. operates within the veterinary services industry, offering a diverse range of veterinary services, including clinical vet services and intensive animal veterinary services, with a focus on beef feedlot and pigs.
YTD Price Performance: 3.70%
Average Trading Volume: 53,024
Technical Sentiment Consensus Rating: Hold
Current Market Cap: A$76.66M
See more insights into AHX stock on TipRanks’ Stock Analysis page.